A potential drug against acute myeloid leukemia shows antitumor effect

by

Hematology and Hemotherapy
–

‘Nature’

In a phase I trial, the menin inhibitor revumenib achieves a complete response in 18 patients with AML, revealing a cause of resistance to this potential new treatment.

Acute myeloid leukemia. Image: ATLAS OF HAEMATOLOGICAL CYTOLOGY.

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

Samsung launches its Galaxy A14, A34 and A54, very attractive entry and mid-range smartphones

Inter survives a draw with Porto and reaches the quarter-finals

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.